|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:SLMO2-ATP5E-GARS (FusionGDB2 ID:HG100533975TG2618) |
Fusion Gene Summary for SLMO2-ATP5E-GARS |
Fusion gene summary |
Fusion gene information | Fusion gene name: SLMO2-ATP5E-GARS | Fusion gene ID: hg100533975tg2618 | Hgene | Tgene | Gene symbol | SLMO2-ATP5E | GARS | Gene ID | 100533975 | 2618 |
Gene name | SLMO2-ATP5E readthrough | phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase | |
Synonyms | - | AIRS|GARS|GARTF|PAIS|PGFT|PRGS | |
Cytomap | ('SLMO2-ATP5E')('GARS') 20q13.32 | 21q22.11 | |
Type of gene | ncRNA | protein-coding | |
Description | - | trifunctional purine biosynthetic protein adenosine-3GAR transformylaseGARS-AIRS-GARTglycinamide ribonucleotide formyltransferaseglycinamide ribonucleotide synthetase-aminoimidazole ribonucleotide synthetase-glycinamide ribonucleotide transformylase | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | |||
Fusion gene scores | * DoF score | 0 X 0 X 0=0 | 5 X 6 X 3=90 |
# samples | 0 | 6 | |
** MAII score |